Germany- based drugs maker Merck’s biotech division is reportedly about to set up an incubator in Israel, operated by its research facility, InterLab.
Merck Serono will invest €10m ($14m) in the venture over seven years and provide a further €3m over the next three years for start-up companies in high tech and life sciences, news provider Globes said.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
